Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.
Press releases published on May 15, 2025
Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 15, 2025
- Duchenne (SGT-003): Participant dosing ongoing in the Phase 1/2 INSPIRE DUCHENNE trial; Solid on track to discuss accelerated pathways with U.S. FDA later in 2025 - - FA (SGT-212): Dosing of first participant anticipated in the second half of 2025 - - …
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement
GlobeNewswire
·
May 15, 2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people …
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
May 15, 2025
Emrosi™ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to approve the transaction to take place …
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
GlobeNewswire
·
May 15, 2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN DIEGO, …
Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
May 15, 2025
– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical response, safety, efficacy, adherence …
SRx Health Solutions Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 15, 2025
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health …
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a …
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 15, 2025
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 15, 2025
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …
Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update
GlobeNewswire
·
May 15, 2025
DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter …
Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2025
GlobeNewswire
·
May 15, 2025
- VCN-01 alcanza los criterios de valoración primarios de eficacia y seguridad para el adenocarcinoma pancreático ductal en el ensayo clínico de Fase 2b VIRAGE - - El 8 de mayo de 2025 se cerró una oferta pública que aumentó el saldo de caja de la empresa …
Dianabol (Dbol) For Sale 2025: Best Legal Dbol Pills, Cycles & Stacking Guide
GlobeNewswire
·
May 15, 2025
New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Dianabol, renowned for its capacity to induce significant muscle hypertrophy, has also been linked to adverse effects such as jaundice, hormonal disruptions, and depressive symptoms. Consequently, …
Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
GlobeNewswire
·
May 15, 2025
New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Introduction In today’s fitness landscape, many are seeking faster, safer paths to noticeable physique changes. Whether it's for trimming body fat or sculpting lean muscle, SARMs—short for Selective …
Best Testosterone Booster for Men – Why TestoPrime is the Top Choice for Libido, Performance, and Vitality
GlobeNewswire
·
May 15, 2025
GLASGOW, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) -- For many men, there’s a silent battle happening within their own bodies—one that often goes unnoticed until it starts to impact daily life. From feeling drained by midday to struggling with …
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
GlobeNewswire
·
May 15, 2025
May 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes …
Organ-on-a-Chip Market Set to Expand with 33.6% CAGR by 2029
GlobeNewswire
·
May 15, 2025
Boston, May 15, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Organ-on-a-Chip: Global Markets” is expected to grow from $153.2 million in 2024 to $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of …
New Biologics Reshape the gMG Landscape, but Growth Opportunities Persist for Established and Pipeline Therapies, According to Spherix Global
GlobeNewswire
·
May 15, 2025
EXTON, PA, May 15, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for generalized myasthenia gravis (gMG) has entered a new era of therapeutic innovation. Since 2022, seven novel targeted biologics have launched, with a robust pipeline poised to continue …
Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published
GlobeNewswire
·
May 15, 2025
In This Arialief Review, You’ll Discover: What Arialief is and how Arialief is marketed as a top neuropathy support supplement The real root causes behind neuropathic pain and why conventional treatments (unlike Arialief) often skip over them A detailed …
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
GlobeNewswire
·
May 15, 2025
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 million dollars of compensatory damages and …